-L Lim Researcher Activity Profile

Research Author Detailed Information 

L Lim Publication Rate By Year

L Lim has published 1 paper(s) in 1990, 1 paper(s) in 1994, 3 paper(s) in 1995, 3 paper(s) in 1998, 1 paper(s) in 1999, 1 paper(s) in 2000, 2 paper(s) in 2001, 1 paper(s) in 2003, 1 paper(s) in 2004, 6 paper(s) in 2007, for a total of 20 research publications in total.

L L Lim Author Information

LAST NAME: lim

FIRST NAME: l

INITIALS: L

AFFILIATION:

Papers

L Lim's Publication Record

1. Interaction between PAK and nck: a template for Nck targets and role of PAK autophosphorylation. Year Published: 2000
Glaxo-IMCB Group, Institute of Molecular & Cell Biology, Singapore 117609, Singapore.
2. Signal therapy for RAS-induced cancers in combination of AG 879 and PP1, specific inhibitors for ErbB2 and Src family kinases, that block PAK activation. Year Published: 2001
Ludwig Institute for Cancer Research, P.O. Box 2008, Royal Melbourne Hospital, Parkville/Melbourne, Australia 3050.
3. Beta1PIX, the PAK-interacting exchange factor, requires localization via a coiled-coil region to promote microvillus-like structures and membrane ruffles. Year Published: 2001
Glaxo-IMCB Group, Institute of Molecular and Cell Biology, 30 Medical Drive, Singapore 117609. mcbkohcg@imcb.nus.edu.sg
4. Novel p21-activated kinase-dependent protrusions characteristically formed at the edge of transformed cells. Year Published: 2004
Department of Biological Sciences and Center for Microscopy and Microanalysis, Bowling Green State University, Bowling Green, OH 43403, USA. heckman@bgnet.bgsu.edu
5. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Year Published: 1994
Institute of Molecular & Cell Biology, National University of Singapore, Kent Ridge.
6. A 68-kDa kinase and NADPH oxidase component p67phox are targets for Cdc42Hs and Rac1 in neutrophils. Year Published: 1995
Department of Neurochemistry, Institute of Neurology, London, United Kingdom.
7. Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family. Year Published: 1995
Institute of Molecular and Cell Biology, National University of Singapore, Kent Ridge, Singapore.
8. Identification and molecular cloning of a p21cdc42/rac1-activated serine/threonine kinase that is rapidly activated by thrombin in platelets. Year Published: 1995
Glaxo-IMCB Group, Institute of Molecular and Cell Biology, National University of Singapore, Kent Ridge, Singapore.
9. Cryptic Rac-binding and p21(Cdc42Hs/Rac)-activated kinase phosphorylation sites of NADPH oxidase component p67(phox). Year Published: 1998
Department of Neurochemistry, Institute of Neurology, 1 Wakefield Street, London WC1N 1PJ, Great Britain.
10. PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Year Published: 1998
Glaxo-IMCB Group, Institute of Molecular and Cell Biology, Singapore.
11. PAK promotes morphological changes by acting upstream of Rac. Year Published: 1998
Glaxo-IMCB Group, Institute of Molecular and Cell Biology, Singapore.
12. Pak functions downstream of Dock to regulate photoreceptor axon guidance in Drosophila. Year Published: 1999
Howard Hughes Medical Institute, Department of Biological Chemistry, School of Medicine, University of California, Los Angeles 90095, USA.
13. Use of multidimensional separation protocols for the purification of trace components in complex biological samples for proteomics analysis. Year Published: 2007
Protein Biosensing and Epithelial Laboratories, Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, P.O. Royal Melbourne Hospital, Parkville, Vic. 3050, Australia. Ed.nice@ludwig.edu.au
14. Use of multidimensional separation protocols for the purification of trace components in complex biological samples for proteomics analysis. Year Published: 2007
Protein Biosensing and Epithelial Laboratories, Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, P.O. Royal Melbourne Hospital, Parkville, Vic. 3050, Australia. Ed.nice@ludwig.edu.au
15. Long-term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusal. Year Published: 2007
Royal Melbourne Hospital, Parkville, Australia, lionellim@optusnet.com.au.
16. Use of multidimensional separation protocols for the purification of trace components in complex biological samples for proteomics analysis. Year Published: 2007
Protein Biosensing and Epithelial Laboratories, Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, P.O. Royal Melbourne Hospital, Parkville, Vic. 3050, Australia. Ed.nice@ludwig.edu.au
17. Long-term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusal. Year Published: 2007
Royal Melbourne Hospital, Parkville, Australia. lionellim@optusnet.com.au
18. Long-term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusal. Year Published: 2007
Royal Melbourne Hospital, Parkville, Australia. lionellim@optusnet.com.au
19. [Modification of immune response after polytrauma and cardiopulmonary bypass by hematopoietic growth factors] Year Published: 2003
Klinische Forschergruppe Schock und MOV, Universitätsklinikum Essen, Hufelandstr. 55, 45122 Essen.
20. Growth hormone receptors--their structure, location and role. Year Published: 1990
Department of Physiology and Pharmacology, University of Queensland, St Lucia, Australia.